Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer

Authors

Institutions

Publication Details

Journal
European Urology Oncology
Published
2025-07-19
DOI
https://doi.org/10.1016/j.euo.2025.04.018
Citations
2
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer

Ray McDermott, Nuria Sala Gonzalez, Emmanuel S. Antonarakis, Jeffrey C. Goh et al.
2 citations
European Urology Oncology
Prostate Cancer Treatment and Research
3.04
article

Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer

Ray McDermott, Nuria Sala Gonzalez, Emmanuel S. Antonarakis, Jeffrey C. Goh, Felipe Rey, Niven Mehra, Richard Greil, Patricio Yañez, Peter C.C. Fong, Se Hoon Park, Christian Hosius, Eric Yi‐Hsiu Huang, Todd L. Saretsky, Yi Ping Cui, Gero Kramer, Sameer R. Ghate, Stephen Begbie, Evan Y. Yu, Maria De Santis, Hiroyoshi Suzuki
article en
2 citations

Abstract

No abstract available for this paper.
European Urology OncologyVol. 8(4)
Universidad de La Frontera (CL), Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Toho University (JP), Radboud University Nijmegen (NL), National Yang Ming Chiao Tung University (TW), University of Auckland (NZ), University of Washington (US), Paracelsus Medical University (AT), Royal Brisbane and Women's Hospital (AU), Auckland City Hospital (NZ), Samsung Medical Center (KR), Radboud University Medical Center (NL), Taipei Veterans General Hospital (TW), Fred Hutch Cancer Center (US), Centro de Investigación y Desarrollo (ES), Cancer Trials Ireland (IE), MSD (Germany) (DE), Toho University Medical Center Sakura Hospital (JP), Port Macquarie Base Hospital (AU), Hospital Universitari de Girona Doctor Josep Trueta (ES), Sidney Kimmel Comprehensive Cancer Center (US), Medical University of Vienna (AT), Charité - Universitätsmedizin Berlin (DE)
Good health and well-being
Openalex Percentile: Top 8%
Prostate Cancer Treatment and Research
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.